Deliver patient value and reimburse your services by innovating your business model
A new way of healthcare is here; services are now an essential part of patient care and will help the pharma industry to make a bigger impact as a healthcare provider. Learn how to put successful services in place to gain better access, reduce costs and help your end-user, the patient. Find out what the most innovative and forward-thinking companies are doing to differentiate their brand in the most competitive times pharma have ever faced. Read more...
Value Beyond the Pill USA 2014 Deliver patient value and reimburse your services by innovating your business model 3 - 4 December 2014 | Philadelphia, PA
14th Bio/Pharma Contact Centers Conference Optimize Contact Center and Patient Service Effectiveness Amid Increasing Regulations, Specialty Products and Social Media Channels 21 - 22 January 2015 | Philadelphia, PA
Social Media in the Pharmaceutical Industry Reflecting on regulatory insights, customer focus, mobile & website advances and the vision for the industry in 2015 21 - 22 January 2015 | Marriott Regents Park Hotel, London, UK
PCC 2015 - CBI's 12th Annual Pharmaceutical Compliance Congress Widely recognized as the most comprehensive, senior-level compliance meeting, CBI's esteemed Pharmaceutical Compliance Congress (PCC) attracts more than 400 industry leaders, including dozens of CCOs and their legal, compliance and regulatory teams. 27 - 28 January 2015 | Washington, DC
Big Data in Pharma Europe Taking the Next Steps on the Big Data Journey to Revolutionise Value-Based Personalised Healthcare 27 - 29 January 2015 | London, UK
Selected Content from Recent Issues of Pharma Marketing News
Drug Industry Rips Into FDA Over Social Media Guidelines
A Summary of Industry Comments Regarding Twitter & Google Adwords
Ever since the epic #FAIL of FDA's July 10, 2014 webinar, which attempted to explain the agency's June 2014 social media guidelines, FDA has been the butt of jokes behind "closed doors" at industry conferences.
Now, the industry's door is open thanks to comments recently submitted to the docket by industry groups and made public by the FDA. It's always interesting and educational to read these comments.
This article summarizes some of the main points made by PhRMA, Washington Legal Foundation (WLF), BIO, Medical Information Working Group (MIWG), Patient, Consumer, and Public Health Coalition, and several pharmaceutical companies, regarding FDA's Draft Guidance on using Internet and social media platforms with character space limitations.
Topics include (partial list):
FDA is Inconsistent, Says PhRMA
What's Good for the Goose (FDA) Should Be Good for the Gander (Pharma)
Online e-Patient & Celebrity Patient Video Testimonials
Anecdotal Experience Marketing
Pharma marketers are capitalizing on the e-Patient movement by leveraging social media, online video, and real patient stories in an effort to become more "patient centric" (see, for example, "Patient Story-telling Marketing"). Add a celebrity spokesperson who is also a patient or a caretaker of a patient and you've got gold!
But in some cases, this practice may be going too far. This article asks the question: Can anecdotal "evidence"/experiences mentioned in patient videos -- even unbranded videos -- cause unnecessary visits to the doctor's office and over prescribing of drugs with serious side effects?
Topics include (partial list):
Real Stories from Real Moms & Daughters
Symptoms & Undocumented Anecdotal Evidence
The Selling of ADHD and Ethics of Disease Awareness Advertising